SCHEMBL9924428

SCHEMBL9924428

O=C(/N=C(/NCc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](O)CC1)c1ccc(F)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMYD3 Q9H7B4 1/20 0.46
MLYCD O95822 1/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PLA2G1B P04054 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
GAA P10253 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ATG4B Q9Y4P1 1/20 0.44
GPR52 Q9Y2T5 1/20 0.44
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
MRGPRX4 Q96LA9 1/20 0.42
P2RX7 Q99572 1/20 0.42
MAPK14 Q16539 1/20 0.41
DRD4 P21917 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17206626 0.90 LMNA (0.42) MRGPRX4P2RX7MAPK14DRD4LMNA
SCHEMBL9924429 0.89 NTRK1 (0.43) SIGMAR1
SCHEMBL9924236 0.88 SMYD3 (0.42) SMYD3MLYCDMEN1KMT2APLA2G1B
SCHEMBL9924275 0.88 THRB (0.45) SMYD3MLYCDMEN1KMT2APLA2G1B
SCHEMBL9924241 0.88 SSTR3 (0.40) POLBP2RX7MAPK14LMNASIGMAR1
SCHEMBL17206619 0.84 EPHX2 (0.48) MEN1KMT2AGPR52HTTLMNA
SCHEMBL9924239 0.84 MAPK14 (0.36) P2RX7MAPK14CCR2
SCHEMBL9924242 0.84 LMNA (0.40) POLBHTTLMNA
SCHEMBL9924268 0.83 SSTR3 (0.46) MEN1KMT2ACYP3A4GAACYP2D6
SCHEMBL9924426 0.83 EPHX1 (0.44) MEN1KMT2ACYP3A4CYP2D6POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed